mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant
A new fast-spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526 recently emerged in New York City and
Read moreA new fast-spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526 recently emerged in New York City and
Read moreAs the pandemic of coronavirus disease 2019 (COVID-19) continues to spread the world over, the focus of scientific research has
Read moreIgor Stagljar made his career building molecular tools to combat cancer. But when the pandemic hit last March, he aimed
Read moreA recent study by researchers in Switzerland found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding
Read moreA brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy
Read moreA team of scientists from the United Kingdom recently conducted a large-scale screening of several membrane-bound and soluble host cell
Read moreResearchers at the University of Texas, USA, valtrex instructions have confirmed the specific mutation in the B.1.1.7 variant of severe
Read moreResearchers in the United States have computed genome-wide covariation within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to investigate interactions
Read moreAmong a large sample of coronavirus disease 2019 (COVID-19) patients, researchers found that a genetic variant – caused by an
Read moreResearchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral
Read more